Phlow’s Post

Today Pharma Manufacturing released a two-part series that covers the transformative efforts underway to re-shore drug manufacturing in the U.S. using advanced technologies and the importance of ongoing government support. Much work has been done to bring visibility to our essential medicine supply chain, but we have a long way to go to truly understanding where the key starting materials and some of these constituent components are being manufactured. Thank you Karen Langhauser for covering this critically important feature story on the status of America’s medicine pharmaceutical sovereignty. Phlow #essentialmedicines #domesticmanufacturing

Insights from our COO, Kevin Webb, were recently featured in Pharma Manufacturing's latest cover story on reshoring pharmaceutical manufacturing in the United States. This two-part series explores domestic manufacturing efforts and highlights the challenges, opportunities, and the critical role of government support in reshoring critical medicines. Read the introduction here: https://lnkd.in/gK_4UM3Z Read Part 1-Targeting government spending here: https://lnkd.in/ggpkaTfq Read Part 2- Sustaining efforts once infrastructure investments dry up here: https://lnkd.in/gz39wdST #reshoring #domesticmanufacturing #supplychain #pharmamanufacturing #innovation

Great article highlighting causes, challenges, progress, and so much work still to be done....One highlight: "Using continuous-flow processes and other green chemistry approaches, Phlow has been able to cut costs and waste, improve quality and yield, and offer a more environmentally friendly alternative to batch manufacturing for several different generic compounds." Worth the read.

A good portion of patent filings in South Africa originate from the United States and Europe with local filings representing a much smaller proportion - the most attention goes to the mining, manufacturing, petrochemicals and pharmaceutical industries. We unpack this and more in our latest report, click here to register and receive a copy: https://lnkd.in/dVNm_kcc #PatentFilings #IntellectualProperty #IPInsights #AfricaIP #ConnectingAfricasPotential

Excited to share our most recent cover story about repatriating generic drugs, APIs and ingredients. In 2020, Meagan Parrish wrote an award-winning piece for us on this topic when it was still very fresh: https://lnkd.in/eiqU7zN8 That got me wondering: Four years later, where do we stand? The government has spent billions of dollars on the pharma reshoring movement, has it paid off? And more importantly, what's next? Those questions led to the creation of this piece, in which I aimed to give a comprehensive overview of where the industry stands with its domestic manufacturing efforts and what needs to happen to sustain progress.

The Iron Law of building wealth. “The biggest mistake that I see investors make is constantly switching strategies. One minute, they’ll chase the speculative pharmaceutical stock that they’re sure will soon get FDA approval for a certain drug, or the mining company that’s about to make the next big find, or the next bit of market momentum.” Read more at https://buff.ly/3Wat3TP

The government’s investments into generic drugs and APIs have created an air of excitement surrounding the westward migration of manufacturing. Now comes arguably the most vital phase of U.S. domestic manufacturing efforts — figuring out where to get the most lasting bang for our reshoring bucks. With the pandemic finally in our rearview, the U.S. has what many industry insiders see as a golden opportunity to candidly assess pharma’s reshoring progress — and create a more formal plan for supply chain resilience. Read the intro here: https://lnkd.in/gK_4UM3Z Part 1 here: https://lnkd.in/ggpkaTfq Part 2 here: https://lnkd.in/gz39wdST #reshoring #domesticmanufacturing #BARDA #ASPR #pharmamanufacturing Marta E. Wosinska, Ph.D., Bikash Chatterjee, Eric Edwards, MD, PhD, Salvatore Mascia, Kevin Webb, Phlow, CONTINUUS Pharmaceuticals

Recent Case Study - Methane System at Large Pharmaceutical Manufacturing Facility Highlighting the benefits of the Pipeotech solid one piece metal gasket used on a new section of pipeline with methane as the main process media. Avoidance of leakage was paramount as methane is a very potent greenhouse gas that ignites easily. For more information head over to our website https://buff.ly/3JgLzEE #pipeotech #energy #oilgas #oilandgas #lng #mining #refinery #petrochemical #technology #shutdowns #maintenance #turnarounds #offshore #pipelineintegrity #chemicalengineering #steam #gaskets #emissons #pharmaceutical #hydrogen #pharmaceuticalindustry

Recent Case Study - Methane System at Large Pharmaceutical Manufacturing Facility Highlighting the benefits of the Pipeotech solid one piece metal gasket used on a new section of pipeline with methane as the main process media. Avoidance of leakage was paramount as methane is a very potent greenhouse gas that ignites easily. For more information head over to our website https://buff.ly/3Hj7pFh #pipeotech #energy #oilgas #oilandgas #lng #mining #refinery #petrochemical #technology #shutdowns #maintenance #turnarounds #offshore #pipelineintegrity #chemicalengineering #steam #gaskets #emissons #pharmaceutical #hydrogen #pharmaceuticalindustry

Recent Case Study - Methane System at Large Pharmaceutical Manufacturing Facility Highlighting the benefits of the Pipeotech solid one piece metal gasket used on a new section of pipeline with methane as the main process media. Avoidance of leakage was paramount as methane is a very potent greenhouse gas that ignites easily. For more information head over to our website https://buff.ly/3Hj7pFh #pipeotech #energy #oilgas #oilandgas #lng #mining #refinery #petrochemical #technology #shutdowns #maintenance #turnarounds #offshore #pipelineintegrity #chemicalengineering #steam #gaskets #emissons #pharmaceutical #hydrogen #pharmaceuticalindustry